Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ocugen Inc
(NQ:
OCGN
)
0.9493
+0.0383 (+4.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocugen Inc
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
32
33
Next >
86 Biggest Movers From Yesterday
November 04, 2021
Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million....
Via
Benzinga
Ocugen Neared $16 Yesterday, But I’ll Eat 4 Hats If It Gets to $32
November 03, 2021
OCGN stock has moved higher despite little evidence anything’s changed regarding Ocugen’s revenue potential in the U.S.
Via
InvestorPlace
Exposures
COVID-19
Most Active Equity Options For Midday - Wednesday, Nov. 3
November 03, 2021
Top Tickers: TSLA, AMC, AMD, AAPL, F, BBBY, LCID, GME, BB, NVDA, Z, UBER, PLTR, HOOD, OCGN, AAL, ATVI, SOFI, PFE, FB.
Via
Talk Markets
Why Ocugen Stock Is Falling Today
November 03, 2021
The biotech received some good news for its most important product. So why is the stock down?
Via
The Motley Fool
Exposures
COVID-19
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 03, 2021
Gainers iRhythm Technologies (NASDAQ:IRTC) stock moved upwards by 52.78% to $117.34 during Wednesday's regular session. iRhythm Technologies's stock is trading at...
Via
Benzinga
BZ Chart Of The Day: Will Ocugen Remember?
November 03, 2021
They say that markets have memories. It’s true, and holders and traders of Ocugen, Inc. (NASDAQ:
Via
Benzinga
Ocugen's India Partnered COVID-19 Vaccine Gets WHO Approval: Report
November 03, 2021
WHO's Technical Advisory Group has recommended the Emergency Use Listing status for Bharat Biotech's COVID-19, Covaxin. Read Next: Ocugen Reverses Course From Monday...
Via
Benzinga
Exposures
COVID-19
Here's Why Ocugen Stock Skyrocketed 64.9% in October
November 03, 2021
The biotech stock is now up a staggering 756% year to date.
Via
The Motley Fool
Exposures
COVID-19
OCGN Stock Alert: WHO Issues Emergency-Use Listing for Covaxin
November 03, 2021
The WHO has finally given Covaxin emergency approval, putting OCGN stock in the spotlight. Will Ocugen be able to bring doses to the U.S.?
Via
InvestorPlace
Exposures
COVID-19
3 Explosive Biotech Stocks -- Could They Shoot Even Higher?
November 03, 2021
These biotech stocks have recently been responsible for a slew of rocketship emojis.
Via
The Motley Fool
PFE Stock Alert: 3 Catalysts Giving Pfizer Stock a Shot in the Arm Today
November 02, 2021
Pfizer is getting ready to start shipping children's vaccines, and PFE stock is rising. That's not the only good news for investors, though.
Via
InvestorPlace
OCGN Stock Alert: Why Ocugen Shares Are Drawing Eyes Ahead of Nov. 3
November 02, 2021
A key WHO ruling that could materialize as soon as tomorrow has investors considering where OCGN stock could be headed this week.
Via
InvestorPlace
Exposures
COVID-19
Check Out What Whales Are Doing With OCGN
November 02, 2021
Someone with a lot of money to spend (and possibly insider knowledge) has taken a bearish stance on Ocugen (NASDAQ:OCGN). And retail traders should know. We noticed this today...
Via
Benzinga
An Approval by WHO Would Not Help Ocugen
November 02, 2021
Ocugen is forging ahead with its plans for regulatory approval, but that doesn't make OCGN stock any more worthy of your capital.
Via
InvestorPlace
Exposures
Product Safety
Why Ocugen Stock Will Probably Soar Tomorrow -- but Shouldn't
November 02, 2021
Investors are excited about a decision that doesn't really benefit Ocugen at this point.
Via
The Motley Fool
Exposures
COVID-19
64 Biggest Movers From Yesterday
November 02, 2021
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on...
Via
Benzinga
What's Going On With Ocugen's Stock?
November 01, 2021
Ocugen, Inc. (NASDAQ: OCGN) shares are trading higher amid heightened interest in the stock from retail traders on social media. According to SwaggyStocks, Ocugen was the fifth...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 01, 2021
Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's regular session. As of 12:30 EST, this security is trading at a volume...
Via
Benzinga
40 Stocks Moving In Monday's Mid-Day Session
November 01, 2021
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares jumped 250% to $8.91 on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the...
Via
Benzinga
Better Therapeutics SPAC Merger: 8 Things for BTTX Stock Investors to Know
November 01, 2021
Better Therapeutics (BTTX) stock is surging higher on Monday after completing its SPAC merger with Mountain Crest Acquisition Corp II.
Via
InvestorPlace
ABVC Stock: The Social Media Chatter That Has ABVC BioPharma Shooting 250% Higher Today
November 01, 2021
ABVC BioPharma (ABVC) stock is rocketing higher on Monday as investors on social media hype up the shares despite a lack of news.
Via
InvestorPlace
OCGN Stock Alert: This Covaxin Update Is Sending Ocugen Rallying
November 01, 2021
Australia just gave a vote of confidence to Covaxin, sending OCGN stock climbing. However, the real catalyst rests in the hands of the WHO.
Via
InvestorPlace
Exposures
COVID-19
2 Best Biotech Stocks to Buy in November
November 01, 2021
Bionano Genomics and Ocugen could both be gearing up for a healthy rally this month.
Via
The Motley Fool
28 Stocks Moving in Monday's Pre-Market Session
November 01, 2021
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) rose 333.9% to $11.02 in pre-market trading. ABVC Biopharma’s S-3 showed registration for $50 million mixed securities shelf...
Via
Benzinga
4 Reasons Why Ocugen Will Make Very Little or No Money From Covaxin
November 01, 2021
Ocuigen is unlikely to be able to get Covaxin widely distributed in the U.S. until Spring 2023. By that time, it won't help OCGN stock much.
Via
InvestorPlace
Exposures
COVID-19
Product Safety
5 Stocks Insiders Are Selling
October 28, 2021
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 27, 2021
Gainers Bio-Path Holdings (NASDAQ:BPTH) shares moved upwards by 9.69% to $5.43 during Wednesday's pre-market session. The company's market cap stands at $37.7...
Via
Benzinga
Tesla Remains Top WallStreetBets Interest; AMD, Ocugen, Facebook And These Are Other Top Trends Today
October 27, 2021
Tesla Inc. (NASDAQ:TSLA) continued to be the most-discusse...
Via
Benzinga
Ocugen Reverses Course From Monday's Massive Surge As COVID-19 Vaccine Partner Faces WHO Setback
October 27, 2021
Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) fell 2% in Tuesday’s regular trading session after seeing strong gains on Monday. What Happened: Ocugen’...
Via
Benzinga
Exposures
COVID-19
Tuesday Market Coverage
October 26, 2021
Thermo Electron fell on the publication of its social responsibility report today.
Via
Talk Markets
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.